M L23 (Lisinopril 5 mg)
Pill with imprint M L23 is Orange, Round and has been identified as Lisinopril 5 mg. It is supplied by Mylan Pharmaceuticals Inc..
Lisinopril is used in the treatment of diabetic kidney disease; heart attack; high blood pressure; heart failure and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M L23
Lisinopril
- Imprint
- M L23
- Strength
- 5 mg
- Color
- Orange
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Angiotensin converting enzyme inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
silicon dioxide,
croscarmellose sodium,
calcium phosphate dihydrate dibasic,
magnesium stearate,
mannitol,
povidone,
corn starch,
sodium lauryl sulfate,
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00378-2073 | Mylan Pharmaceuticals Inc. |
| 51079-0981 | UDL Laboratories Inc. |
| 63874-0558 | Altura Pharmaceuticals Inc. (repackager) |
Related Images for "M L23"
More about lisinopril
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 564 Reviews
- Drug class: Angiotensin Converting Enzyme Inhibitors
- FDA Alerts (1)
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.